| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,506 |
5,525 |
$469K |
| 36415 |
Collection of venous blood by venipuncture |
2,347 |
2,162 |
$279K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,818 |
3,510 |
$247K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
166 |
161 |
$27K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
430 |
398 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
94 |
93 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
79 |
75 |
$5K |
| 81003 |
|
114 |
99 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
241 |
225 |
$3K |
| 83655 |
|
36 |
36 |
$2K |
| T1015 |
Clinic visit/encounter, all-inclusive |
15 |
15 |
$1K |
| 85018 |
|
53 |
53 |
$1K |
| 90686 |
|
468 |
456 |
$838.25 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
105 |
100 |
$735.00 |
| 80053 |
Comprehensive metabolic panel |
473 |
445 |
$683.96 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,178 |
1,158 |
$655.21 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25 |
25 |
$542.82 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
371 |
348 |
$418.37 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
37 |
26 |
$392.83 |
| 90670 |
|
281 |
278 |
$329.89 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
20 |
13 |
$219.32 |
| 90656 |
|
87 |
86 |
$191.62 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
13 |
$128.11 |
| 84443 |
Thyroid stimulating hormone (TSH) |
242 |
235 |
$104.82 |
| 86803 |
|
49 |
42 |
$71.04 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
143 |
138 |
$60.90 |
| 90461 |
|
81 |
78 |
$22.70 |
| 90677 |
|
84 |
84 |
$0.02 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
35 |
26 |
$0.00 |
| 80061 |
Lipid panel |
161 |
153 |
$0.00 |
| 90633 |
|
39 |
39 |
$0.00 |
| 90697 |
|
58 |
57 |
$0.00 |
| 90698 |
|
27 |
26 |
$0.00 |
| 90680 |
|
38 |
37 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
42 |
40 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
17 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |